The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Glycotope GmbH (Inst)
Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): Results from the randomized phase II RESGEX study.
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck Serono; MSD Oncology; Novartis
Research Funding - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Merck Serono; MSD Oncology
 
Andrzej Kawecki
Honoraria - Bristol-Myers Squibb; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
Research Funding - Glycotope GmbH (Inst)
 
Andreas Dietz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology
Research Funding - Glycotope GmbH (Inst)
 
Bogdan Zurawski
No Relationships to Disclose
 
Michael Schenker
Research Funding - Abbvie; Amgen; Astellas Oncology; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Pharmaceuticals; Bristol-Myers Squibb; Daiichi Sankyo; Gilead Sciences; Helsinn Healthcare; Lilly; Merck Serono; Merck Sharp & Dohme; Mylan; Novartis; Pfizer; PharmaMar; Roche; Samsung; Syntha Pharmaceutical
 
Bozena Kukielka-Budny
Research Funding - Glycotope GmbH
 
Philippe Schafhausen
Research Funding - Glycotope GmbH (Inst)
 
Anca C. Mihailov
Research Funding - Glycotope GmbH (Inst)
Travel, Accommodations, Expenses - Janssen; Pfizer; Sanofi
 
Sebastian Ochenduszko
Research Funding - Glycotope GmbH (Inst)
 
Ilaria Imarisio
Research Funding - Glycotope GmbH (Inst)
 
Simona Mihutiu
Research Funding - Glycotope GmbH (Inst)
 
Cristina-Marinela Oprean
Honoraria - Astellas Oncology; AstraZeneca; Boehringer Ingelheim; Genentech; Impala Pharma Consulting; Pfizer; Roche; Sandoz; Teva
Consulting or Advisory Role - Pfizer; Sandoz
Research Funding - Abbvie (Inst); Acraf (Inst); Amgen (Inst); Astellas Oncology (Inst); Boehringer Ingelheim (Inst); Genentech (Inst); Glycotope GmbH (Inst); Janssen (Inst); Samsung (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Acraf; AstraZeneca; Merck; Pierre Fabre; Roche
 
Gunnar Folprecht
Honoraria - Merck KGaA
Consulting or Advisory Role - Baxalta; Bayer; Bristol-Myers Squibb; Lilly/ImClone; Merck KGaA; Mundipharma; Roche/Genentech; Sanofi/Aventis; SERVIER
Research Funding - Merck KGaA
 
Alina Turcu
Research Funding - Glycotope GmbH (Inst)
 
Sylvie Rottey
Research Funding - Glycotope GmbH (Inst)
 
Philippe Debourdeau
Consulting or Advisory Role - Bayer
Research Funding - Glycotope GmbH (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
Javier Lavernia
Research Funding - Glycotope GmbH (Inst)
 
Bruno Dietrich
Employment - Glycotope GmbH
 
Alfredo Zurlo
Employment - Glycotope GmbH
Leadership - Glycotope GmbH
 
Jerome Fayette
Leadership - Glycotope GmbH
Honoraria - AstraZeneca; Bristol-Myers Squibb